Liminatus Pharma Highlights Life-Saving Potential of Next-Generation Pancreatic Cancer Screening Test
Collaboration with Samda Biolab and INNOCS AI Targets Early Detection for Thousands of Patients Worldwide LA PALMA, CA, UNITED STATES, August 18, 2025 /EINPresswire.com/ -- Liminatus Pharma, Inc. (Nasdaq: LIMN) today reaffirmed the promising …